N. Homann et al., THE SIGNIFICANCE ABERRANT P53 PROTEIN IN HEAD AND NECK TUMORS AND ITSINFLUENCE ON TUMOR PROLIFERATION AND DIFFERENTIATION, HNO. Hals-, Nasen-, Ohrenarzte, 41(5), 1993, pp. 254-260
Mutation of the tumor suppressor gene p53 is the most frequent genetic
alteration of human tumors. Our systematic immunohistochemical analys
is of the p53 phenotype and the comparison to proliferation and differ
entiation has revealed that over 50% of the squamous cell carcinomas o
f the head and neck show p53 accumulation of aberrant p53 protein. Nor
mal epithelia did not show p53 accumulation and benign lesions only in
exceptional cases. Expression of aberrant p53 was invariably confined
to dysplastic cells in close vicinity to the tumor and to invasive, d
edifferentiated tumor cells with high proliferative potential, as reve
aled by expression of the histone H3 gene and of the simple epithelial
type cytokeratins. We discuss the possible clinical value of the immu
nohistochemical screening of tumor patients for the status of the p53
gene.